Research

Daniel ODay
Favicon Fierce Biotech

CEO O’Day tells Fierce how Gilead reached ‘critical mass’

After a run of dealmaking, Gilead CEO Daniel O'Day told Fierce that any future M&A activity will only be done to complement the existing strategy.
Darren Incorvaia Sep 16, 2026 8:00am
FDA
Favicon Fierce Biotech

AACR: Pazdur bemoans state of FDA, warns of political influence

Apr 18, 2026 4:00am
concept of growth and then decline
Favicon Fierce Biotech

Biopharma R&D pipeline shrinks for 1st time in 30 years: report

Apr 3, 2026 8:13am
Heart-shaped stone in a zen garden
Favicon Fierce Biotech

How GLP-1s help the heart relax: study

Mar 2, 2026 7:01pm
Person wearing a Lilly vest standing next to an Nvidia GPU
Favicon Fierce Biotech

Lilly debuts Nvidia supercomputer with fanfare and focus

Feb 27, 2026 1:37pm
AI
Favicon Fierce Biotech

BMS and Evinova pen global development partnership

Feb 9, 2026 2:33pm